Amgen Inc. (AMGN)
Amgen Statistics
Share Statistics
Amgen has 537.65M shares outstanding. The number of shares has increased by 0.14% in one year.
| Shares Outstanding | 537.65M |
| Shares Change (YoY) | 0.14% |
| Shares Change (QoQ) | -0.06% |
| Owned by Institutions (%) | 77.6% |
| Shares Floating | 536.43M |
| Failed to Deliver (FTD) Shares | 5 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 14.08M, so 2.62% of the outstanding shares have been sold short.
| Short Interest | 14.08M |
| Short % of Shares Out | 2.62% |
| Short % of Float | 2.62% |
| Short Ratio (days to cover) | 4.73 |
Valuation Ratios
The PE ratio is 34.48 and the forward PE ratio is 12.8. Amgen's PEG ratio is -0.87.
| PE Ratio | 34.48 |
| Forward PE | 12.8 |
| PS Ratio | 4.22 |
| Forward PS | 3.9 |
| PB Ratio | 23.99 |
| P/FCF Ratio | 13.57 |
| PEG Ratio | -0.87 |
Enterprise Valuation
Amgen has an Enterprise Value (EV) of 189.13B.
| EV / Sales | 5.66 |
| EV / EBITDA | 14.16 |
| EV / EBIT | 16.46 |
| EV / FCF | 18.2 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 10.23.
| Current Ratio | 1.26 |
| Quick Ratio | 0.95 |
| Debt / Equity | 10.23 |
| Debt / EBITDA | 4.5 |
| Debt / FCF | 5.78 |
| Interest Coverage | 2.3 |
Financial Efficiency
Return on Equity is 69.59% and Return on Invested Capital is 8.91%.
| Return on Equity | 69.59% |
| Return on Assets | 4.45% |
| Return on Invested Capital | 8.91% |
| Revenue Per Employee | $1.19M |
| Profits Per Employee | $146.07K |
| Employee Count | 28,000 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.84 |
Taxes
| Income Tax | 519M |
| Effective Tax Rate | 11.26% |
Stock Price Statistics
The stock price has increased by 5.42% in the last 52 weeks. The beta is 0.58, so Amgen's price volatility has been higher than the market average.
| Beta | 0.58 |
| 52-Week Price Change | 5.42% |
| 50-Day Moving Average | 303.9 |
| 200-Day Moving Average | 305.62 |
| Relative Strength Index (RSI) | 36.23 |
| Average Volume (20 Days) | 3.25M |
Income Statement
In the last 12 months, Amgen had revenue of 33.42B and earned 4.09B in profits. Earnings per share was 7.56.
| Revenue | 33.42B |
| Gross Profit | 20.57B |
| Operating Income | 7.26B |
| Net Income | 4.09B |
| EBITDA | 13.36B |
| EBIT | 7.76B |
| Earnings Per Share (EPS) | 7.56 |
Balance Sheet
The company has 11.97B in cash and 60.1B in debt, giving a net cash position of -48.13B.
| Cash & Cash Equivalents | 11.97B |
| Total Debt | 60.1B |
| Net Cash | -48.13B |
| Retained Earnings | 0 |
| Total Assets | 91.84B |
| Working Capital | 5.93B |
Cash Flow
In the last 12 months, operating cash flow was 11.49B and capital expenditures -1.1B, giving a free cash flow of 10.39B.
| Operating Cash Flow | 11.49B |
| Capital Expenditures | -1.1B |
| Free Cash Flow | 10.39B |
| FCF Per Share | 19.21 |
Margins
Gross margin is 61.53%, with operating and profit margins of 21.71% and 12.24%.
| Gross Margin | 61.53% |
| Operating Margin | 21.71% |
| Pretax Margin | 13.79% |
| Profit Margin | 12.24% |
| EBITDA Margin | 39.96% |
| EBIT Margin | 21.71% |
| FCF Margin | 31.1% |
Dividends & Yields
AMGN pays an annual dividend of $11.51, which amounts to a dividend yield of 3.28%.
| Dividend Per Share | $11.51 |
| Dividend Yield | 3.28% |
| Dividend Growth (YoY) | 5.78% |
| Payout Ratio | 152.25% |
| Earnings Yield | 2.9% |
| FCF Yield | 7.37% |
Analyst Forecast
The average price target for AMGN is $324, which is 17% higher than the current price. The consensus rating is "Hold".
| Price Target | $324 |
| Price Target Difference | 17% |
| Analyst Consensus | Hold |
| Analyst Count | 21 |
Stock Splits
The last stock split was on Nov 22, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 22, 1999 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 1.79 |
| Piotroski F-Score | 7 |